|
|
|
|
|
Product Name
|
DPP8 antibody - Catalytic domain
|
| |
See all DPP8 antibodies (3)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Rabbit polyclonal to DPP8 - Catalytic domain
|
|
Immunogen
|
Synthetic peptide based on the catalytic domain of human DPP8.
(Peptide available as ab44595.)
|
|
Reacts with
|
Hu, Rat
|
|
Predicted to react
(species key)
|
Ms (Due to sequence homology)
|
|
Specificity
|
This antibody recognises all four forms of DPP8. This antibody does not recognize other DPP family members.
We have a range of domain specific antibodies for this target. For a full list please see all DPP8 antibodies
|
|
Tested applications
(see key)
|
IHC-P, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions IHC-P: 1/250. WB: 1/1000 - 1/5000. Predicted molecular weight: 100 kDa.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Positive control
(see definition)
|
WISH cells, DU145 cells and lysates of LNCaP and Hs1.Tes.
|
|
Cellular localization
|
Cytoplasmic
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> DPPs
|
|
Relevance
|
DPP-8 (Dipeptidyl Peptidase-8) is a serine proteinase of the clan SC. The clan SC proteinases have a catalytic triad of Ser-Asp-His, and like other Serine proteinases, the active site serine is in a Gly-Xaa-Ser-Xaa -Gly orientation. DPP-8 is a member of a broader family of dipeptidyl peptidases including DPP-2, DPP-4, FAP/Seprase, DPP-6, DPP-9, DPP-10, which have differing substrate specificity and tissue localizations. DPP-8 is most closely related to DPP-9, with which it shares 58% identical residues. DPP-8 has only 27% identity with DPP-4, but seems to have similar substrate specificity. Although DPP-4 and FAP-a form a surface-bound heterodimer in some cells, and homodimers in others, DPP-8 seems to be a cytoplasmic protein. The original publication determined that DPP-8 was a monomer, active at neutral pH, and later publications suggest DPP-8 is a homodimer. Substrates include glucagon-like peptide-1, glucagon-like peptide-2, neuropeptide-Y, but with different efficacy relative to DPP-4. DPP-8 has been found in highest abundance in the testis and placenta, but is found in most tissues. Several different splice variants of DPP-8 were seen in the different tissues, with some tissue-specific expression. Four different human sequences are reported to date; 898, 882, 847 and 782 amino acids in length. The longest sequence of human DPP-8 has a predicted mass of 103.4 kDa, and pI of 5.42. The 882, 847 and 782 amino acid forms are predicted at 101.4, 97.5 and 89.9 kDa respectively, with pIs of 5.26, 5.55 and 5.07. Another three partial sequences that are alternatively spliced have deletions in the catalytic domain, and may not be catalytically active. Over expression of DPP-8 caused decreased viability in cells, but a catalytically dead mutant of DPP-8 had the same results, thus some of the DPP-8 activity may be non-enzymatic. Two of the splice variants have longer aminotermini (16 AA insert), and this may affect localization in the cell.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Rabbit
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Storage buffer
|
Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol, PBS, 0.5M Sodium chloride Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this DPP8 antibody - Catalytic domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
References for DPP8 antibody - Catalytic domain (ab42077)
|
|
This product has been used in:
Geiss-Friedlander R et al. The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides. J Biol Chem 284:27211-9 (2009). WB; Human. PubMed: 19667070
If you publish research using ab42077 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to DPP8
|
| |
DPP8 antibody - Catalytic domain - more information
|
Customer reviews (feedback) regarding DPP8 antibody - Catalytic domain |
Customer FAQs regarding DPP8 antibody - Catalytic domain |
Protocols for DPP8 antibody - Catalytic domain |
Price and availability of products related to DPP8 antibody - Catalytic domain |
| |
DPP8 antibody - Catalytic domain - related products:
|
|
|
| |
DPP8 antibody - Catalytic domain - other tools:
|
Contact Abcam with a Technical Enquiry about DPP8 antibody - Catalytic domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"